ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout 
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup 
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Oregon on behalf of investors who purchased GNC Holdings Inc. (NYSE:GNC) securities between May 2, 2013 and October 22, 2015.
Click here to learn about the case: http://docs.wongesq.com/GNC-Info-Request-Form-1010. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period, Defendants issued materially false and/or misleading information and/or failed to disclose that: (1) GNC unlawfully sold thousands of units of products in Oregon that contained picamilon; (2) GNC unlawfully sold thousands of units of products in Oregon that contained BMPEA; and (3) as a result of the foregoing, the Company’s public statements were materially false and misleading.
On October 22, 2015, the Oregon Department of Justice filed a lawsuit against GNC Holdings claiming that the company’s nutritional and dietary supplements contain picamilon and BMPEA. Said Attorney General Rosenblum, “It is scary to know that certain products sold by GNC contain an ingredient that is not even labeled—let alone approved in the United States.”
If you suffered a loss in GNC Holdings you have until December 28, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/GNC-Info-Request-Form-1010.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
